Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    A sitewide NIH banner about website changes was added, and the footer revision changed from v3.7.1 to v3.7.2; the page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:18:48.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:27:11.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content. Access to the study details is blocked on this page.
    Difference
    18%
    Check dated 2026-09-23T00:45:40.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The bottom of the page shows Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a site version update rather than changes to trial details.
    Difference
    0.0%
    Check dated 2026-09-15T23:51:15.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's deployment without altering the study information.
    Difference
    0.0%
    Check dated 2026-09-01T19:45:00.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    A new funding line indicating the 2016 U.S. NIH grant/contract was added to the study record. This addition provides funding attribution within the study's details.
    Difference
    0.0%
    Check dated 2026-08-25T19:40:07.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.